118 related articles for article (PubMed ID: 20145638)
21. Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series.
Tanasi I; Bonifacio M; Pizzolato M; Irene Grifoni F; Sciumè M; Elena C; Benvenuti P; Mannelli F; Parente R; Schena D; Scaffidi L; Bonadonna P; Papayannidis C; Rondoni M; Criscuolo M; Vannucchi AM; Triggiani M; Martinelli G; Krampera M; Zanotti R
Br J Haematol; 2021 May; 193(4):845-848. PubMed ID: 33754335
[No Abstract] [Full Text] [Related]
22. Genotypic and phenotypic characteristics of Chinese neonates with cutaneous mastocytosis: a case report and literature review.
Li Y; Li X; Liu X; Kang L; Liu X
J Int Med Res; 2020 Sep; 48(9):300060520952621. PubMed ID: 32883129
[TBL] [Abstract][Full Text] [Related]
23. Paediatric mastocytosis: a systematic review of 1747 cases.
Méni C; Bruneau J; Georgin-Lavialle S; Le Saché de Peufeilhoux L; Damaj G; Hadj-Rabia S; Fraitag S; Dubreuil P; Hermine O; Bodemer C
Br J Dermatol; 2015 Mar; 172(3):642-51. PubMed ID: 25662299
[TBL] [Abstract][Full Text] [Related]
24. Pediatric cutaneous mastocytosis and
Ertugrul A; Bostanci I; Ozturk Kaymak A; Gurkan A; Ozmen S
Allergy Asthma Proc; 2019 Mar; 40(2):123-128. PubMed ID: 30819282
[No Abstract] [Full Text] [Related]
25. Letter: Cutaneous mastocytosis with systemic involvement mimicking clinical and dermatoscopically multiple melanocytic nevi.
Gutiérrez-González E; Ginarte M; Toribio J
Dermatol Online J; 2011 Nov; 17(11):15. PubMed ID: 22136871
[TBL] [Abstract][Full Text] [Related]
26. The genetic basis of mast cell activation disease - looking through a glass darkly.
Molderings GJ
Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106
[TBL] [Abstract][Full Text] [Related]
27. Mastozytose - Pathogenese, Klinik und Therapie.
Wagner N; Staubach P
J Dtsch Dermatol Ges; 2018 Jan; 16(1):42-59. PubMed ID: 29314684
[No Abstract] [Full Text] [Related]
28. Acute lymphoblastic leukemia and cutaneous mastocytosis in two children.
Masserot C; Adjaoud D; Haouy S; Deswarte C; Ballerini P; Landman-Parker J
Pediatr Blood Cancer; 2008 Sep; 51(3):444-5. PubMed ID: 18491374
[No Abstract] [Full Text] [Related]
29. Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis.
Hartmann K; Wardelmann E; Ma Y; Merkelbach-Bruse S; Preussner LM; Woolery C; Baldus SE; Heinicke T; Thiele J; Buettner R; Longley BJ
Gastroenterology; 2005 Sep; 129(3):1042-6. PubMed ID: 16143141
[TBL] [Abstract][Full Text] [Related]
30. Detection of the germline KIT S476I mutation in a kindred with familial mastocytosis associated with gastrointestinal stromal tumors.
Peters F; Fiebig B; Lundberg P; Jaspers NI; Holzapfel B; Ghadimi MPH; Drebber U; Tuchscherer A; Ullrich R; Hartmann K; Tantcheva-Poór I
J Allergy Clin Immunol Pract; 2021 May; 9(5):2123-2125.e1. PubMed ID: 33422680
[No Abstract] [Full Text] [Related]
31. Spectrum of mast cell activation disorders.
Petra AI; Panagiotidou S; Stewart JM; Conti P; Theoharides TC
Expert Rev Clin Immunol; 2014 Jun; 10(6):729-39. PubMed ID: 24784142
[TBL] [Abstract][Full Text] [Related]
32. Identification of KIT activating mutations in paediatric solitary mastocytoma.
Ma D; Stence AA; Bossler AB; Hackman JR; Bellizzi AM
Histopathology; 2014 Jan; 64(2):218-25. PubMed ID: 24128084
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of three variants of cutaneous mastocytosis as the presenting sign of systemic mastocytosis with somatic c-kit D816V point mutation.
Lesnoni La Parola I; Cannistraci C; Izzi S; Pisani F; Amantea A; Rongioletti F
Int J Dermatol; 2014 Oct; 53(10):1265-8. PubMed ID: 24738598
[No Abstract] [Full Text] [Related]
34. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
[TBL] [Abstract][Full Text] [Related]
35. Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations.
Fett NM; Teng J; Longley BJ
Am J Dermatopathol; 2013 Feb; 35(1):113-6. PubMed ID: 22892471
[TBL] [Abstract][Full Text] [Related]
36. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior.
Büttner C; Henz BM; Welker P; Sepp NT; Grabbe J
J Invest Dermatol; 1998 Dec; 111(6):1227-31. PubMed ID: 9856847
[TBL] [Abstract][Full Text] [Related]
37. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
Sotlar K
Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612
[TBL] [Abstract][Full Text] [Related]
39. A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy.
Zhang LY; Smith ML; Schultheis B; Fitzgibbon J; Lister TA; Melo JV; Cross NC; Cavenagh JD
Leuk Res; 2006 Apr; 30(4):373-8. PubMed ID: 16183119
[TBL] [Abstract][Full Text] [Related]
40. Systemic mastocytosis associated with t(8;21) acute myeloid leukemia in a child: detection of the D816A mutation of KIT.
Yabe M; Masukawa A; Kato S; Yabe H; Nakamura N; Matsushita H
Pediatr Blood Cancer; 2012 Dec; 59(7):1313-6. PubMed ID: 22847983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
